NCT00274300View on ClinicalTrials.gov

Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

July 31, 2005

Conditions

HSV-2

Interventions

BIOLOGICAL

pPJV7630 administered by PMED

Trial Locations (2)

77058

Center for Clinical Studies, Houston

97210

Westover Heights Clinic, Portland

Sponsors

Lead Sponsor

All Listed Sponsors

lead

PowderMed

INDUSTRY